ADA FORECAST, Vol. 9 (September–October, 1956), pp. 1–4.
2.
ADA FORECAST, Vol. 10 (May–June 1957), pp. 1–3.
3.
ADA FORECAST, Vol. 10 (July–August, 1957), pp. 1–3.
4.
ADA FORECAST, Vol. 11 (January–February, 1958), pp. 1–6.
5.
DIABETES, Vol. 6 (January–February, 1957), pp. 1–93.
6.
DIABETES, Vol. 6 (March–April, 1957), pp. 135–154; 191–196.
7.
DIABETES, Vol. 6 (May–June 1957), pp. 259–292.
8.
DIABETES, Vol. 6 (September–October, 1957), pp. 408–417.
9.
DIABETES, Vol. 6 (November–December, 1957), pp. 534–535.
10.
DIABETES, Vol. 7 (January–February, 1958), pp. 53–59.
11.
THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, Vol. 164 (July 20, 1957), pp, 1333–1335.
12.
Tornow, Abraham M., and others: Hypoglycemic Effects of Chlorpropamide: Diabetes, Vol. 8 (January–February, 1959), pp. 1–6.
13.
Root, M.A., Ph.D., and others: Pharmacology of Chlorpropamide: Diabetes, Vol. 8 (Jan.–Feb., 1959), pp. 7–13.
14.
Pfizer Laboratories: Report On Diabinese, January 1959.
15.
Pfizer Laboratories: Personal communication.
16.
SteinerDonald F.WilliamsRobert H.: Action of Phenethylbiguanide and Related Compounds: Diabetes, Vol. 8, (March–April, 1959), 154–157.
17.
Williams, Robert H., and others: Hypoglycemic Actions of Phenethyl-, Amyl-, and Isoamyl-Diguinide: Diabetes, Vol. 7, (March–April, 1958), pp. 87–93.
18.
JoslinElliott P.: Diabetes: First Practical Gains of “The Experimental Era”: World Wide Abstracts of General Medicine, Vol. 1 (November, 1958), pp. 11–19.
19.
U. S. Vitamin and Pharmaceutical Corporation: DBI—brochure.
20.
U. S. Vitamin and Pharmaceutical Corporation: Personal communication.
